Related Experiment Video

Updated: Jun 25, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Closing the Gap Between Trial and Clinical Reality in Long-term LVAD Use Outcomes

Federica Guidetti1,2, Mateusz Sokolski3,4

  • 1Department of Clinical Science and Education, Södersjukhuset; Karolinska Institute; Stockholm, Sweden.

ESC Heart Failure
|June 24, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
05:18

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Experiment Videos

Last Updated: Jun 25, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
05:18

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Articles linked to this work by shared authors, journal, and citation graph.

Trends in Mortality, Heart Transplantation and Left Ventricular Assist Device use in Advanced Heart Failure between 2003 and 2022: data from the Swedish Heart Failure Registry.

European journal of heart failure·2026

Post-viral myocarditis.

Heart failure reviews·2026

Clonal haematopoiesis and outcomes after acute coronary syndrome: a systematic review and meta-analysis.

ESC heart failure·2026

Longitudinal loop diuretic use in patients with HFrEF initiated with sodium-glucose cotransporter 2 inhibitors.

European heart journal. Cardiovascular pharmacotherapy·2026

Clinical characteristics of patients with cardiogenic shock after out-of-hospital cardiac arrest (OHCA) compared to patients with cardiogenic shock without OHCA.

Cardiology journal·2026

"Real-world prognostic performance of different severe and advanced heart failure definitions: Data from the Swedish Heart Failure Registry".

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

New Evidence in Heart Failure: 2026 Update.

ESC heart failure·2026

Dapagliflozin effects on right ventricular function, pulmonary pressure and coupling: a propensity score analysis from the RIVED-HF.

ESC heart failure·2026

Identifying clinical subtypes in acute dyspnoea patients admitted to the emergency department: a secondary model-based clustering of prospective cohorts.

ESC heart failure·2026

Characterising Clinically Recognised Hypertrophic Cardiomyopathy in six European Countries Using Real-World Data.

ESC heart failure·2026

Distinct prognostic trajectories of heart failure phenotypes following kidney transplantation.

ESC heart failure·2026

Timing-specific factors associated with early, intermediate, and late readmission after heart failure hospitalization.

ESC heart failure·2026

Comprehensive Genomic Profiling Timeliness Beyond Laboratory Turnaround Time: A Patient-Facing Pathway Analysis.

Asia-Pacific journal of clinical oncology·2026

Beyond random splits: A hierarchical benchmark of transferability and reliability in PROTAC activity prediction.

Computational biology and chemistry·2026

California to vote on $16 billion to boost research.

Science (New York, N.Y.)·2026

Risk Assessment in Peacekeeping: Are Visual Sparse Models Transparent?

Risk analysis : an official publication of the Society for Risk Analysis·2026

Refusal-aware evaluation of frontier AI models available in June 2026 using the Japanese National License Examination for Pharmacists: a comparative study.

Journal of educational evaluation for health professions·2026

Does receiving positive or negative feedback change our memories about a decision we made?

Cognitive processing·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us